what was glp 1 originally used for GLP-1 receptor agonists are increasingly to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 | Summary

F.CoppoL

For more on proper storage procedures, see the peptide storage guide

Despite the best efforts to lose weight, many people with obesity struggle to achieve and maintain weight loss due to physiological responses that favor weight regain

While both GLP 1 & GIP therapy and GLP 1s are GLP-1 receptor agonists that help with weight loss, GLP 1 & GIP therapy also includes a second mechanismGIP receptor activationwhich enhances its effectiveness

Massa et al., 2017) and with Platelet Activating Factor Receptor (PAFr) (Jen et al., 2013), as demonstrated in endothelial cells and upper airway epithelial cells, respectively

diet changes or medication can help if it doesn't